COVID Vaccine Shows Effectiveness in Phase 1 Trial | City of Hope | targets both the spike and nucleocapsid proteins; Phase 2 clinical trial for immunocompromised cancer patients, who have difficulty producing antibodies and largely depend on T cells
No comments:
Post a Comment